MedTrace Logo

Treatment of IgAN With Multi-glycoside of Tripterygium Wilfordii HOOK. f.

NCT02187900 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2014-07-11

No results posted yet for this study

Summary

The purpose of this study is to determine whether Multi-glycoside of Tripterygium Wilfordii HOOK. f. is effective and safe in the treatment of IgA nephropathy.

Conditions

Interventions

DRUG

Multi-glycoside of Tripterygium Wilfordii HOOK. f. (TWH)

The dosage of 40 mg of Multi-glycoside of Tripterygium Wilfordii HOOK. f. was divided into 2 equal doses at 12-hour intervals for 6 months.

DRUG

Mycophenolate mofetil (MMF)

Mycophenolate mofetil 1.5mg/day for the treatment of IgAN for 6 months

Sponsors & Collaborators

  • Second Xiangya Hospital of Central South University

    lead OTHER

Principal Investigators

  • Shenghua Zhou, MD · the second xiangya hospital of CSU

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2015-08-31
Completion
2015-09-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02187900 on ClinicalTrials.gov